Lab-grown stem cells may restore damaged eye surfaces
NCT ID NCT00845117
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a graft made from a patient's own or donor stem cells can repair the cornea's surface in people with limbal stem cell deficiency, a condition that causes pain, scarring, and vision loss. A small biopsy of limbal tissue is taken from a healthy eye or donor, stem cells are grown into a sheet in the lab, and then transplanted onto the damaged eye. The trial measures improvements in vision, surface healing, and blood vessel growth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cultivated limbal stem cell graft
- What this could lead to
- If successful, this approach could restore a clear corneal surface and improve vision in people with limbal stem cell deficiency, potentially reducing the need for corneal transplants.
- What could go wrong
- This is a small, early-stage study with 21 participants, so results may not apply to everyone. Risks include graft failure, infection, or rejection, and long-term benefits are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIMBAL STEM CELL DEFICIENCY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Antwerp
Antwerp, Edegem, 2650, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 500-Patient study aims to map rare eye Disease's natural course
- New eye drops aim to repair cornea damage in rare vision disorder
- Scientists hunt for genes behind worst cases of rare eye condition
- Scientists hunt for biomarkers to unlock rare eye disease treatments
- Could Lab-Grown eye cells restore sight? new trial begins
- Eye membrane patch shows promise for blinding corneal disease